1 – 10 of 225
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers
(
- Contribution to journal › Article
-
Mark
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden
(
- Contribution to journal › Article
-
Mark
Are population level familial risks and germline genetics meeting each other?
(
- Contribution to journal › Scientific review
-
Mark
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
(
- Contribution to journal › Article
-
Mark
Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development
(
- Contribution to journal › Article
-
Mark
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
(
- Contribution to journal › Article
- 2022
-
Mark
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
(
- Contribution to journal › Article
-
Mark
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia : a CRuCIAL study
(
- Contribution to journal › Letter
-
Mark
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
(
- Contribution to journal › Article
-
Mark
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6
(
- Contribution to journal › Letter